WAYNE, Pa., April 11, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, has announced the launch of the UroLift System in Japan for treating benign prostatic hyperplasia (BPH), or enlarged prostate. The UroLift System is now available for purchase, effective immediately. Teleflex previously announced reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo).
Perrigo Shares Pop On Raised FY22 Guidance Surpassing Consensus Estimates
Perrigo Company plc’s (NYSE: PRGO) Q1 FY22 sales increased 6.4% Y/Y to $1.07 billion, almost in line with the consensus of $1.1…
